Danish drugmaker Novo Nordisk said it plans to make its new obesity pill available through telehealth platforms like Ro and WeightWatchers once it gets U.S. approval, Bloomberg News reported on Friday... ...

This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily Manufacturing Dive newsletter. Dive Brief: Eli Lilly said it will build a $6.5 billion factory in Houston focused on manufacturing the company’s first obesity pill and other small molecule medicines. The 236-acre site will produce active pharmaceutical ingredients, among them orforglipron, a small, oral GLP-1 receptor agonist, according to a news release. The molecule agonist is up f ...